Company Overview

Update
Founded:
2011
Headquarters:
Paris-l'hopital
Funding:
$41.7M
Categories:
Biotechnology
Description:
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Detailed Description

Update

Paris-based GenSight Biologics is a privately owned biopharmaceutical company, dedicated to the development and commercialization of gene therapy based treatments of retinal degenerative diseases.

Based on recent results obtained by the teams of its scientific founders, the company develops innovative approaches to (i) prevent retinal degeneration in selected pathological conditions and (ii) to restore vision in patients suffering from very low vision or blindness.

Funding Rounds (1) - $41.7M

Update

Board Members and Advisors (2)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    Paris-l'hopital,

    FRA

Images (1)

Update
  • 709b41b936df8f56cb3e44b0987ff4dd